Susan Richards Windham-Bannister's Net Worth
$320
Who is Susan Richards Windham-Bannister?
Susan Richards Windham-Bannister does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Humacyte, Inc., CAMBRIDGE BANCORP, Aridis Pharmaceuticals, Inc., and Histogen Inc..
SEC CIK
Susan Richards Windham-Bannister's CIK is 0001713760
Past Insider Trading and Trends
2023 was Susan Richards Windham-Bannister's most active year for acquiring shares with 5 total transactions. Susan Richards Windham-Bannister's most active month to acquire stocks was the month of May. 2023 was Susan Richards Windham-Bannister's most active year for disposing of shares, totalling 1 transactions. Susan Richards Windham-Bannister's most active month to dispose stocks was the month of May. 2024 saw Susan Richards Windham-Bannister paying a total of $0.00 for 250,000 shares, this is the most they've acquired in one year. In 2023 Susan Richards Windham-Bannister cashed out on 5,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Humacyte, Inc. (HUMA) Snapshot price: $5.2985
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CAMBRIDGE BANCORP (CATC) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 347 |
—
|
—
| 347 |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aridis Pharmaceuticals, Inc. (ARDS) Snapshot price: $0.064
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
May 4 - Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Histogen Inc. (HSTO) Snapshot price: $0.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |